6-53269248-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021814.5(ELOVL5):c.779C>T(p.Ser260Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
ELOVL5
NM_021814.5 missense
NM_021814.5 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: 6.49
Genes affected
ELOVL5 (HGNC:21308): (ELOVL fatty acid elongase 5) This gene belongs to the ELO family. It is highly expressed in the adrenal gland and testis, and encodes a multi-pass membrane protein that is localized in the endoplasmic reticulum. This protein is involved in the elongation of long-chain polyunsaturated fatty acids. Mutations in this gene have been associated with spinocerebellar ataxia-38 (SCA38). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24869308).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELOVL5 | NM_021814.5 | c.779C>T | p.Ser260Phe | missense_variant | 8/8 | ENST00000304434.11 | NP_068586.1 | |
ELOVL5 | NM_001242828.2 | c.860C>T | p.Ser287Phe | missense_variant | 9/9 | NP_001229757.1 | ||
ELOVL5 | NM_001301856.2 | c.779C>T | p.Ser260Phe | missense_variant | 8/8 | NP_001288785.1 | ||
ELOVL5 | NM_001242830.2 | c.654C>T | p.Leu218Leu | synonymous_variant | 7/7 | NP_001229759.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELOVL5 | ENST00000304434.11 | c.779C>T | p.Ser260Phe | missense_variant | 8/8 | 1 | NM_021814.5 | ENSP00000306640.6 | ||
ELOVL5 | ENST00000542638.5 | c.654C>T | p.Leu218Leu | synonymous_variant | 7/7 | 1 | ENSP00000440728.2 | |||
ELOVL5 | ENST00000370918.8 | c.860C>T | p.Ser287Phe | missense_variant | 9/9 | 2 | ENSP00000359956.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 18, 2021 | The c.860C>T (p.S287F) alteration is located in exon 9 (coding exon 8) of the ELOVL5 gene. This alteration results from a C to T substitution at nucleotide position 860, causing the serine (S) at amino acid position 287 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;D
Sift4G
Uncertain
D;D
Polyphen
0.0080
.;B
Vest4
MutPred
0.45
.;Loss of disorder (P = 0.0107);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.